국립중앙도서관 "우편 복사 서비스"로 연결 됩니다.
RISS
KISSSecondary systemic (AA) amyloidosis is a severe complication of progressed Crohn disease (CD) characterized by the deposition of amyloid A in body organs and tissues. Various therapeutic approaches have been recommended, however there is still no effe...
다국어 입력
あ
ぁ
か
が
さ
ざ
た
だ
な
は
ば
ぱ
ま
や
ゃ
ら
わ
ゎ
ん
い
ぃ
き
ぎ
し
じ
ち
ぢ
に
ひ
び
ぴ
み
り
う
ぅ
く
ぐ
す
ず
つ
づ
っ
ぬ
ふ
ぶ
ぷ
む
ゆ
ゅ
る
え
ぇ
け
げ
せ
ぜ
て
で
ね
へ
べ
ぺ
め
れ
お
ぉ
こ
ご
そ
ぞ
と
ど
の
ほ
ぼ
ぽ
も
よ
ょ
ろ
を
ア
ァ
カ
サ
ザ
タ
ダ
ナ
ハ
バ
パ
マ
ヤ
ャ
ラ
ワ
ヮ
ン
イ
ィ
キ
ギ
シ
ジ
チ
ヂ
ニ
ヒ
ビ
ピ
ミ
リ
ウ
ゥ
ク
グ
ス
ズ
ツ
ヅ
ッ
ヌ
フ
ブ
プ
ム
ユ
ュ
ル
エ
ェ
ケ
ゲ
セ
ゼ
テ
デ
ヘ
ベ
ペ
メ
レ
オ
ォ
コ
ゴ
ソ
ゾ
ト
ド
ノ
ホ
ボ
ポ
モ
ヨ
ョ
ロ
ヲ
―
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
예시)
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
А
Б
В
Г
Д
Е
Ё
Ж
З
И
Й
К
Л
М
Н
О
П
Р
С
Т
У
Ф
Х
Ц
Ч
Ш
Щ
Ъ
Ы
Ь
Э
Ю
Я
а
б
в
г
д
е
ё
ж
з
и
й
к
л
м
н
о
п
р
с
т
у
ф
х
ц
ч
ш
щ
ъ
ы
ь
э
ю
я
′
″
℃
Å
￠
￡
￥
¤
℉
‰
＄
％
Ｆ
￦
㎕
㎖
㎗
ℓ
㎘
㏄
㎣
㎤
㎥
㎦
㎙
㎚
㎛
㎜
㎝
㎞
㎟
㎠
㎡
㎢
㏊
㎍
㎎
㎏
㏏
㎈
㎉
㏈
㎧
㎨
㎰
㎱
㎲
㎳
㎴
㎵
㎶
㎷
㎸
㎹
㎀
㎁
㎂
㎃
㎄
㎺
㎻
㎽
㎾
㎿
㎐
㎑
㎒
㎓
㎔
Ω
㏀
㏁
㎊
㎋
㎌
㏖
㏅
㎭
㎮
㎯
㏛
㎩
㎪
㎫
㎬
㏝
㏐
㏓
㏃
㏉
㏜
㏆
RISS 인기검색어
크론병에 동반된 속발성 아밀로이드증에서 infliximab 치료 = CASE REPORT : Secondary amyloidosis complication of Crohn disease treated with infliximab
한글로보기https://www.riss.kr/link?id=A101758808
- 저자
- 발행기관
- 학술지명
- 권호사항
-
발행연도
2015
-
작성언어
Korean
- 주제어
-
KDC
510.5
-
자료형태
학술저널
- 발행기관 URL
-
수록면
102-105(4쪽)
-
KCI 피인용횟수
0
- DOI식별코드
- 제공처
-
0
상세조회 -
0
다운로드
부가정보
다국어 초록 (Multilingual Abstract)
Secondary systemic (AA) amyloidosis is a severe complication of progressed Crohn disease (CD) characterized by the deposition of amyloid A in body organs and tissues. Various therapeutic approaches have been recommended, however there is still no effective treatment. Recently, several case reports have demonstrated the effects of anti-tumor necrosis factor-α therapy in patients with AA amyloidosis associated with CD. We report on a 35-year-old female patient with CD complicated by AA amyloidosis in the gastrointestinal tract and renal involvement, who was treated with infliximab. The infliximab therapy improved the gastrointestinal symptoms and decreased the serum creatinine.
참고문헌 (Reference)
1 Park YK, "Systemic amyloidosis with Crohn’s disease treated with infliximab" 14 : 431-432, 2008
2 Serra I, "Systemic amyloidosis in inflammatory bowel disease:retrospective study on its prevalence, clinical presentation, and outcome" 4 : 269-274, 2010
3 Wester AL, "Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998" 7 : 295-300, 2001
4 Boscá MM, "Secondary amyloidosis in Crohn’s disease:treatment with tumour necrosis factor inhibitor" 55 : 294-295, 2006
5 Cabezuelo JB, "Infliximab in the treatment of amyloidosis secondary to Crohn’s disease" 32 : 385-388, 2012
6 Iizuka M, "Infliximab as a treatment for systemic amyloidosis associated with Crohn’s disease" 55 : 744-745, 2006
7 Ueda M, "FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis" 33 : 2260-2270, 2006
8 Dember LM, "Eprodisate for the treatment of renal disease in AA amyloidosis" 356 : 2349-2360, 2007
9 Iizuka M, "Efficacy of scheduled infliximab maintenance therapy on systemic amyloidosis associated with Crohn’s disease" 17 : E67-E68, 2011
10 Greenstein AJ, "Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients" 71 : 261-270, 1992
1 Park YK, "Systemic amyloidosis with Crohn’s disease treated with infliximab" 14 : 431-432, 2008
2 Serra I, "Systemic amyloidosis in inflammatory bowel disease:retrospective study on its prevalence, clinical presentation, and outcome" 4 : 269-274, 2010
3 Wester AL, "Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998" 7 : 295-300, 2001
4 Boscá MM, "Secondary amyloidosis in Crohn’s disease:treatment with tumour necrosis factor inhibitor" 55 : 294-295, 2006
5 Cabezuelo JB, "Infliximab in the treatment of amyloidosis secondary to Crohn’s disease" 32 : 385-388, 2012
6 Iizuka M, "Infliximab as a treatment for systemic amyloidosis associated with Crohn’s disease" 55 : 744-745, 2006
7 Ueda M, "FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis" 33 : 2260-2270, 2006
8 Dember LM, "Eprodisate for the treatment of renal disease in AA amyloidosis" 356 : 2349-2360, 2007
9 Iizuka M, "Efficacy of scheduled infliximab maintenance therapy on systemic amyloidosis associated with Crohn’s disease" 17 : E67-E68, 2011
10 Greenstein AJ, "Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients" 71 : 261-270, 1992
11 Obici L, "AA amyloidosis: basic knowledge, unmet needs and future treatments" 142 : w13580-, 2012
동일학술지(권/호) 다른 논문
-
- 영남대학교 의과대학
- ( Ji Hye Seo )
- 2015
-
CASE REPORT : Page kidney after botulinum toxin injection during chiropractic care
- 영남대학교 의과대학
- ( Han Min Park )
- 2015
-
양측성 신동맥 협착증에서 발생한 급성 비대상성 심부전과 급성 신손상
- 영남대학교 의과대학
- 정호진 ( Ho Jin Jung )
- 2015
-
- 영남대학교 의과대학
- ( Eun Woo Choi )
- 2015
분석정보
인용정보 인용지수 설명보기
학술지 이력
| 연월일 | 이력구분 | 이력상세 | 등재구분 |
|---|---|---|---|
| 2027 | 평가예정 | 재인증평가 신청대상 (재인증) | |
| 2022-01-01 | 학술지명변경 | 한글명 : Yeungnam University Journal of Medicine -> Journal of Yeungnam Medical Science외국어명 : 미등록 -> Journal of Yeungnam Medical Science |  |
| 2021-01-01 | 평가 | 등재학술지 유지 (재인증) | |
| 2018-01-01 | 평가 | 등재학술지 선정 (계속평가) | |
| 2016-01-01 | 평가 | 등재후보학술지 선정 (신규평가) |  |
학술지 인용정보
| 기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
|---|---|---|---|
| 2016 | 0.03 | 0.03 | 0 |
| KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
| 0 | 0 | 0 | 0 |
이 자료와 함께 이용한 RISS 자료
나만을 위한 추천자료
